2014
DOI: 10.12740/pp/24434
|View full text |Cite
|
Sign up to set email alerts
|

„Mid-stimulation psychosis” in the course of in vitro fertilization procedure with the use of clomiphene citrate and bromocriptine – case study

Abstract: CelDotychczas opisano kilka przypadków psychoz indukowanych stosowaniem cytrynianu klomifenu, używanego w celu stymulacji owulacji. Jednak dane dotyczące rozpowszechnienia objawów psychotycznych wśród kobiet leczonych z powodu niepłodności są niejednoznaczne. Nadal niewiele wiadomo na temat ewentualnych psychiatrycznych powikłań preparatów farmakologicznych stosowanych w technikach rozrodu wspomaganego. Prezentujemy przypadek pacjentki, u której w przebiegu drugiej z kolei procedury zapłodnienia pozaustrojowe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…Knowing that low estrogen periods are times of special risk for psychotic episodes is especially useful for secondary prevention (prevention of recurrent episodes of psychosis) in women diagnosed with schizophrenia. Relapse can be prevented by increasing the dose of AP medication at low estrogen times in the menstrual month[ 46 , 47 ], during the postpartum period[ 48 ], after menopause[ 49 , 50 ], whenever therapeutic estrogen is stopped[ 51 , 52 ], or during therapy with anti-estrogen drugs[ 53 , 54 ]. These theoretical examples suggest that effective prevention of schizophrenia may, in the future, be possible in a sex-specific manner[ 55 , 56 ], though this is not the case presently.…”
Section: Potential Prevention Strategiesmentioning
confidence: 99%
“…Knowing that low estrogen periods are times of special risk for psychotic episodes is especially useful for secondary prevention (prevention of recurrent episodes of psychosis) in women diagnosed with schizophrenia. Relapse can be prevented by increasing the dose of AP medication at low estrogen times in the menstrual month[ 46 , 47 ], during the postpartum period[ 48 ], after menopause[ 49 , 50 ], whenever therapeutic estrogen is stopped[ 51 , 52 ], or during therapy with anti-estrogen drugs[ 53 , 54 ]. These theoretical examples suggest that effective prevention of schizophrenia may, in the future, be possible in a sex-specific manner[ 55 , 56 ], though this is not the case presently.…”
Section: Potential Prevention Strategiesmentioning
confidence: 99%